August 15, 2022

Volume XII, Number 227

Advertisement
Advertisement

August 12, 2022

Subscribe to Latest Legal News and Analysis

DOE Issues FOA To Establish Its 7th Clean Energy Manufacturing Innovation Institute

On June 23, 2022, DOE’s Office of Energy Efficiency & Renewable Energy (EERE) issued a funding opportunity announcement (FOA) of $70 million to establish the 7th Clean Energy Manufacturing Innovation Institute. DOE EERE states that “[t]his new coalition of industry, academia, and government partners aims to develop and scale technologies to electrify industrial process heating and reduce emissions across the industrial sector.” The institute along with a new federal advisory committee, will focus on decarbonization technologies to help the United States reach its net-zero emissions goal by 2050. The Secretary of Energy will appoint 16 to 20 committee members for the federal advisory committee based on individual qualifications and a need to ensure diverse viewpoints, subject matter expertise, and regional knowledge. Nominations are now open until August 1, 2022, and can be submitted here. The new institute will join DOE’s six Manufacturing USA® institutes funded through EERE’s Advanced Manufacturing Office (AMO). DOE will hold an informational webinar on the new institute on July 14, 2022. Concept papers for the institute are due on August 9, 2022.

©2022 Bergeson & Campbell, P.C.National Law Review, Volume XII, Number 195
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether...

202-557-3801
Advertisement
Advertisement
Advertisement